Call Us: 1.800.873.5297

By

Reglan® Linked to Tardive Dyskinesia

reglan-linkedReglan®(metoclopramide) is a doctor-prescribed medication that increases the contractions of the stomach and small intestine, helping with the passage of food. Prescribed to both children and adults, Reglan® has been used to treat symptoms of diabetic gastroparesis (a condition in which the stomach does not contract) and gastroesophageal reflux (GER).  It is also given to cancer chemotherapy and surgery patients to prevent nausea and vomiting.

Recently, serious side effects including a neurological disorder called tardive dyskinesia, has been linked to Reglan®. The risk of this potentially permanent movement disorder is thought to increase with extended use of Reglan®. Other serious complications that can occur with Reglan® (metoclopramide) use include:

  • Kidney Disease
  • Death
  • Coma

On February 26, 2009, the U.S. Food and Drug Administration (FDA) began requiring that drug labels from manufacturers of metoclopramide include a Black Box warning about the risks associated with long-term or high-dose usage.

If you or a loved one has been diagnosed with tardive dyskinesia or have had other health complications after using this dangerous drug, please contact a personal injury attorney at Schlichter, Bogard & Denton for a free consultation. Attorneys are now investigating cases throughout the country.

Additional Adverse Conditions Caused by Reglan® (metroclopramide)

Since no known treatment exists for tardive dyskinesia, you should be aware of the risks of taking Reglan® for longer than three months. The side effects can be mild or more serious, like that of tardive dyskinesia. The often irreversible side effects of tardive dyskinesia have the following characteristics:

  • Jerking movements with the tongue, face, mouth and jaw
  • Random movements of the arms, legs and trunk
  • Involuntary movement of the hands and fingers
  • Mask-like appearance in the face
  • Rapid eye blinking
  • Constant Lip smacking
  • Impaired movement of the hands and fingers

Types of Reglan® Currently Prescribed

Approximately two million people are currently using Reglan® (metoclopramide) in one of its many forms. And, according to the FDA, is the most common cause of drug-induced movement disorders found in pharmaceutical injury cases. The forms in which Reglan® is prescribed are:

  • Reglan® tablets
  • Reglan® Oral Disintegrating Tablets
  • Metoclopramide Oral Solution
  • Reglan® Injection

Evaluating Your Legal Options

If you have suffered from the side effects of Reglan® use and are concerned about its long-term effects, contact the pharmaceutical injury attorneys at Schlichter, Bogard & Denton. We’ll schedule a no-cost, no-obligation consultation so that you can privately discuss your case and consider your legal options. As a national leader in pharmaceutical litigation, our law firm has the case experience you need.

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.